Superb Drugs Pvt Ltd - pharma in Calcutta, West Bengal, India. FY 2026 financials and compliance.
CIN U70109WB1973PTC010840 Incorporated 25 June 1973 ROC Kolkata HQ Calcutta, West Bengal, India
Active Private Limited Company pharma
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
Locked
In full report
Net profit · Latest
Locked
In full report
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹72.55 Lakh
Issued & subscribed
Open charges
₹7.96 Cr
Secured borrowings
Company age
53 yrs
Est. 1973
Last financials
Mar 2014
Balance sheet date

About Superb Drugs Pvt Ltd

Data last updated: 07 March 2026

Superb Drugs Pvt Ltd is a private limited company based in Calcutta, West Bengal, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 25 June 1973, the company has been in operation for over 53 years.

Registered with ROC Kolkata under CIN U70109WB1973PTC010840.

Capital: an authorised share capital of ₹75 Lakh and a paid-up capital of ₹72.55 Lakh. It is led by directors including Raj Kamal Kanoria and Ram Balak Sah.

Last AGM: 30 September 2014. Financial statements filed for year ended 31 March 2014. Office: 1/3/3D Dum Roadcalcutta, West Bengal, India – 700002.

As per MCA filings, the company has open charges of ₹7.96 Cr on record.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company Details of Superb Drugs Pvt Ltd
CIN U70109WB1973PTC010840
Registration Number 010840
Incorporation Date 25 June 1973
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2014
Date of Balance Sheet 31 March 2014
Compliance Status Active Non-Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    1/3/3D Dum Roadcalcutta, West Bengal, India – 700002
  • Industry
    Pharma, Drug Formulation & Development
Company report
Superb Drugs Pvt Ltd - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Superb Drugs Pvt Ltd report

Financials, compliance, directors, charges, ownership and filings for Superb Drugs Pvt Ltd in one report.

10-year financials Directors & ownership Charges & compliance

Board of Directors of Superb Drugs Pvt Ltd

Superb Drugs Pvt Ltd is currently managed by 3 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Raj Kamal Kanoria Director 14 Jan 2016 10 Years 6 Months Current
Ram Balak Sah Director 01 Dec 2014 11 Years 7 Months Current
Ajay Baral Director 03 Nov 2014 11 Years 8 Months Current

Financials of Superb Drugs Pvt Ltd FY 2014 filings available

Premium access

Ten-year financial statements for Superb Drugs Pvt Ltd

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Superb Drugs Pvt Ltd

Open charges
₹7.96 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Idbi Bank Ltd.₹4.75 Cr
United Bank of India₹3.21 Cr
Latest charge details
DateLenderAmountStatus
26 Aug 2009 Idbi Bank Ltd. ₹4.75 Cr Open
24 Apr 2004 United Bank of India ₹2.86 Cr Open
28 May 2002 United Bank of India ₹35 Lakh Open

Total charge records: 3 View all charges

Employees and EPFO Compliance at Superb Drugs Pvt Ltd

View historical data on people associated with Superb Drugs Pvt Ltd, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Superb Drugs Pvt Ltd

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Superb Drugs Pvt Ltd

Premium access

GST registrations and filing compliance for Superb Drugs Pvt Ltd

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Superb Drugs Pvt Ltd

Premium access

Credit ratings, litigation, and regulatory alerts for Superb Drugs Pvt Ltd

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Superb Drugs Pvt Ltd

Premium access

MSME payment history for Superb Drugs Pvt Ltd

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Superb Drugs Pvt Ltd

Premium access

Corporate group structure for Superb Drugs Pvt Ltd

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Superb Drugs Pvt Ltd

Premium access

MCA filings and documents for Superb Drugs Pvt Ltd

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Superb Drugs Pvt Ltd

Directors
14 Jan 2016
Raj Kamal Kanoria was appointed as a Director on 14 Jan 2016 & has been associated with this company since 10 years 6 months.
Directors
01 Dec 2014
Ram Balak Sah was appointed as a Director on 01 Dec 2014 & has been associated with this company since 11 years 7 months.
Directors
03 Nov 2014
Ajay Baral was appointed as a Director on 03 Nov 2014 & has been associated with this company since 11 years 8 months.
Activity
30 Sep 2014
Superb Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records.
Activity
31 Mar 2014
Superb Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Kolkata I.
Charges
26 Aug 2009
A charge with Idbi Bank Ltd. amounted to Rs. 475.00 Lakh with Charge ID 10181224 was registered on 26 Aug 2009.

Frequently Asked Questions about Superb Drugs Pvt Ltd

Superb Drugs Pvt Ltd is an active private limited company in the pharma sector based in Calcutta, West Bengal, India. It was incorporated on 25 June 1973 (53+ years old) and is registered under CIN U70109WB1973PTC010840.

The current directors of Superb Drugs Pvt Ltd are:

The primary industry of Superb Drugs Pvt Ltd is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Superb Drugs Pvt Ltd can be reached at the registered office: 133D Dum Roadcalcutta, West Bengal, India – 700002.

The authorised capital is ₹75 Lakh, and the paid-up capital is ₹72.55 Lakh.

The company has its registered office at 133D Dum Roadcalcutta, West Bengal, India – 700002.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available